Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
Phynova will adopt a China-centric business plan; Crown...
Charles River Labs noted a slowdown in the worldwide CRO...
China has enacted the third major revision of its patent...
aTyr Pharma will use a Hong Kong lab to help develop...
Cheezheng Tibetan Medicine was approved to IPO on the...
Beijing announced a 10 billion RMB ($1.5 billion) fund to...
Golden Meditech raised $40 million in private equity for...
China is expected to announce a $1.5 trillion, five-year...
Sinopharm Group will pay $198 million for a 60% stake in...
Novartis may IPO on the Shanghai stock exchange, which...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
